Talk:Bibhitaki: Difference between revisions
Dridhabala (talk | contribs) No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
|data4 = Available | |data4 = Available | ||
|label5 = Contributors | |label5 = Contributors | ||
|data5 = | |data5 = Dravyaguna Team | ||
|label6 = Year of publication | |label6 = Year of publication | ||
|data6 = | |data6 = 2026 | ||
|label7 = Publisher | |label7 = Publisher | ||
|data7 = [[Charak Samhita Research, Training and Skill Development Centre]] | |data7 = [[Charak Samhita Research, Training and Skill Development Centre]] | ||
| Line 24: | Line 24: | ||
Beleric myrobalan | Beleric myrobalan | ||
==Therapeutic Uses== | {{Short description|Species of tree in the family Combretaceae}} | ||
{{Infobox organism | |||
| name = ''Terminalia bellirica'' | |||
| image = Terminalia bellirica - Baheda - Bastar, Chhattisgarh W IMG 4066.jpg | |||
| image_caption = Fruit and foliage of ''Terminalia bellirica'' | |||
| kingdom = [[Plant]]ae | |||
| clade1 = [[Angiosperms]] | |||
| clade2 = [[Eudicots]] | |||
| clade3 = [[Rosids]] | |||
| order = [[Myrtales]] | |||
| family = [[Combretaceae]] | |||
| genus = [[Terminalia (plant)|''Terminalia'']] | |||
| species = '''''T. bellirica''''' | |||
| binomial = ''Terminalia bellirica'' | |||
| binomial_authority = ([[Joseph Gaertner|Gaertner]]) [[William Roxburgh|Roxb.]] | |||
}} | |||
'''Therapeutic Monograph: ''Terminalia bellirica'' (Bibhitaka)''' is a summary of the botanical profile, ethnobotanical uses, phytochemical composition, and contemporary pharmacological evaluation of the medicinal plant ''[[Terminalia bellirica]]''. | |||
== Botanical Profile & Traditional Context == | |||
''Terminalia bellirica'' (Gaertn.) Roxb., known traditionally as '''Bibhitaka''' (or Baheda), is a large deciduous tree native to the forests of the [[Indian subcontinent]] and [[Southeast Asia]]. Belonging to the family [[Combretaceae]], it is one of the three foundational fruits constituting the classic [[Ayurveda|Ayurvedic]] formulation '''[[Triphala]]''' (alongside ''[[Terminalia chebula]]'' and ''[[Phyllanthus emblica]]''). | |||
In traditional medicine systems ([[Ayurveda]], [[Unani medicine|Unani]], and [[Siddha medicine|Siddha]]), Bibhitaka is classified as a ''Rasayana'' (rejuvenator). It is traditionally indicated for respiratory disorders (cough, [[asthma]]), digestive ailments, ocular diseases, and hair care. | |||
==Therapeutic Uses in Ayurveda== | |||
Vomiting (chardi), Cough (Kasa), Worms (krimiroga), Constipation (vibandha), Hoarseness of voice (svarabheda), Eye diseases (netraroga)<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:17</ref> | Vomiting (chardi), Cough (Kasa), Worms (krimiroga), Constipation (vibandha), Hoarseness of voice (svarabheda), Eye diseases (netraroga)<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:17</ref> | ||
| Line 492: | Line 516: | ||
== Current researches == | == Current researches == | ||
=== Phytochemical Composition === | |||
The therapeutic efficacy of ''Terminalia bellirica'' is attributed to its rich profile of bioactive [[secondary metabolites]], predominantly concentrated in its fruit rind. | |||
* '''Phenolic Acids & Tannins:''' High concentrations of [[gallic acid]], [[ellagic acid]], chebulagic acid, and chebulinic acid. These compounds drive its potent antioxidant and antimicrobial profiles. | |||
* '''Flavonoids:''' [[Luteolin]], [[rutin]], and [[quercetin]]. | |||
* '''Saponins & Sterols:''' [[Beta-Sitosterol|β-sitosterol]], belleric acid, and bellericoside. | |||
* '''Fixed Oils:''' The seed kernels contain essential fatty acids, primarily [[linoleic acid|linoleic]] and [[oleic acid]]s. | |||
== Pharmacological Activities & Therapeutic Efficacy == | |||
=== Metabolic Regulation & Anti-Diabetic Activity === | |||
Bibhitaka exhibits significant efficacy in managing [[metabolic syndrome]], specifically [[type 2 diabetes mellitus]] and [[hyperlipidemia]]. | |||
* '''Mechanism:''' Phytochemicals like gallic and ellagic acids inhibit key carbohydrate-hydrolyzing enzymes (α-glucosidase and α-amylase), reducing postprandial blood glucose spikes. Furthermore, it enhances insulin sensitivity by upregulating [[PPAR-gamma]] receptors. | |||
* '''Scientific Evidence:''' Aqueous extracts of ''T. bellirica'' have been shown to significantly decrease plasma glucose levels and improve lipid profiles in streptozotocin-induced diabetic animal models, showing comparable efficacy to standard oral hypoglycemic agents.<ref name="Sabu2009"/> | |||
=== Respiratory and Anti-Asthmatic Effects === | |||
Traditionally used to alleviate chronic cough and [[bronchitis]], modern pharmacology validates its role as a [[bronchodilator]] and [[antitussive]]. | |||
* '''Mechanism:''' The extract exerts an [[anticholinergic]] (antimuscarinic) effect, blocking [[calcium channels]] to relax smooth airway muscles. | |||
* '''Scientific Evidence:''' Research highlights that the crude extract of ''T. bellirica'' mediates bronchodilatory activity via dual inhibition of [[phosphodiesterase]] (PDE) and calcium influx, validating its traditional use in asthma.<ref name="Khan2008"/> | |||
=== Hepatoprotective and Antioxidant Activity === | |||
The fruit rind provides potent defense against [[oxidative stress]] and chemical-induced [[hepatotoxicity|liver injury]]. | |||
* '''Mechanism:''' It scavenges free radicals (O<sub>2</sub><sup>•−</sup>, OH<sup>•</sup>) and restores endogenous antioxidant enzymes, such as [[superoxide dismutase]] (SOD), [[catalase]] (CAT), and [[glutathione]] (GSH), while reducing [[lipid peroxidation]]. | |||
* '''Scientific Evidence:''' Clinical and ''in vivo'' models have shown that ''T. bellirica'' extract significantly reduces elevated serum liver enzymes ([[Alanine transaminase|ALT]], [[Aspartate transaminase|AST]]) induced by hepatotoxins like [[carbon tetrachloride]] (CCl<sub>4</sub>) or [[paracetamol|acetaminophen]].<ref name="Shinde2012"/> | |||
=== Antimicrobial and Anti-Biofilm Efficacy === | |||
Bibhitaka possesses a broad-spectrum antimicrobial profile against pathogenic bacteria, fungi, and viruses. | |||
* '''Mechanism:''' [[Tannins]] disrupt bacterial cell walls and precipitate microbial proteins, inhibiting the formation of [[dental plaque]]s and [[biofilm]] matrices. | |||
* '''Scientific Evidence:''' Evaluation against multidrug-resistant clinical isolates confirmed that ''T. bellirica'' extracts exhibit strong inhibitory activity against pathogens including ''[[Staphylococcus aureus]]'' and ''[[Pseudomonas aeruginosa]]''.<ref name="Aqil2007"/> | |||
=== Hyperuricemia and Gout Management === | |||
Clinical research has focused on Bibhitaka's ability to lower [[uric acid]] levels. | |||
* '''Mechanism:''' It acts as a natural inhibitor of '''[[xanthine oxidase]]''', the enzyme responsible for converting purines into uric acid. | |||
* '''Scientific Evidence:''' A randomized, double-blind, placebo-controlled clinical trial demonstrated that a standardized extract of ''T. bellirica'' significantly reduced serum uric acid levels in human subjects with [[hyperuricemia]], displaying a dose-dependent efficacy comparable to the drug [[febuxostat]] without the associated side effects.<ref name="Usharani2016"/> | |||
== Safety, Toxicity, and Dosage == | |||
* '''Acute Toxicity:''' Animal models indicate that ''Terminalia bellirica'' possesses a high safety profile, with the Median Lethal Dose ([[LD50]]) of the aqueous extract exceeding 2000 mg/kg body weight. | |||
* '''Contraindications:''' Due to its mild laxative and astringent properties, excessive doses may cause mild gastrointestinal discomfort. Safety during pregnancy and lactation has not been fully established; use should be supervised by a medical professional. | |||
* '''Standard Therapeutic Dosage:''' | |||
** ''Crude Powder (Churna):'' 3–6 g daily. | |||
** ''Standardized Extract:'' 250–500 mg twice daily. | |||
== Summary of Therapeutic Profile == | |||
{| class="wikitable sortable" style="text-align: left;" | |||
|+ Therapeutic Applications of ''Terminalia bellirica'' | |||
! Indication | |||
! Active Biomolecules | |||
! Primary Pharmacological Action | |||
|- | |||
| '''[[Hyperuricemia]] ([[Gout]])''' | |||
| Gallic acid, Ellagic acid | |||
| [[Xanthine oxidase]] inhibition | |||
|- | |||
| '''[[Type 2 Diabetes]]''' | |||
| Chebulagic acid, Flavonoids | |||
| [[Alpha-glucosidase inhibitor|α-glucosidase inhibition]], [[PPAR-gamma]] activation | |||
|- | |||
| '''[[Asthma]] & [[Bronchitis]]''' | |||
| Saponins, Tannins | |||
| [[Calcium channel blocker|Calcium channel blockade]], [[Bronchodilator|Bronchodilation]] | |||
|- | |||
| '''Hepatic Damage''' | |||
| Phenolic compounds | |||
| Free radical scavenging, SOD/CAT restoration | |||
|} | |||
== References == | |||
{{Reflist|refs= | |||
<ref name="Sabu2009">{{cite journal |last1=Sabu |first1=M. C. |last2=Kuttan |first2=R. |year=2009 |title=Antidiabetic activity of medicinal plants and its relationship with their antioxidant property |journal=Journal of Ethnopharmacology |volume=81 |issue=2 |pages=155–160 |doi=10.1016/S0378-8741(02)00054-9}}</ref> | |||
<ref name="Khan2008">{{cite journal |last1=Khan |first1=A. U. |last2=Gilani |first2=A. H. |year=2008 |title=Pharmacological justification for the medicinal use of ''Terminalia bellirica'' in gastrointestinal and respiratory disorders |journal=Journal of Ethnopharmacology |volume=116 |issue=3 |pages=393–397 |doi=10.1016/j.jep.2007.12.006 |pmid=18242042}}</ref> | |||
<ref name="Shinde2012">{{cite journal |last1=Shinde |first1=A. |last2=et al. |year=2012 |title=Hepatoprotective activity of ''Terminalia bellirica'' Roxb. fruit against carbon tetrachloride-induced hepatic damage |journal=Indian Journal of Experimental Biology |volume=50 |issue=4 |pages=271–277 |pmid=22540166}}</ref> | |||
<ref name="Aqil2007">{{cite journal |last1=Aqil |first1=F. |last2=Ahmad |first2=I. |year=2007 |title=Antibacterial properties of certain Indian medicinal plants against multi-drug resistant clinical isolates |journal=Phytotherapy Research |volume=21 |issue=11 |pages=1017–1024 |doi=10.1002/ptr.2199 |pmid=17600863}}</ref> | |||
<ref name="Usharani2016">{{cite journal |last1=Usharani |first1=P. |last2=et al. |year=2016 |title=A randomized, double-blind, placebo- and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of ''Terminalia bellirica'' in secondary hyperuricemia |journal=Clinical Pharmacology: Advances and Applications |volume=8 |pages=51–59 |doi=10.2147/CPAA.S100521 |pmid=27354832 |pmc=4912116}}</ref> | |||
}} | |||
[[Category:Medicinal plants]] | |||
[[Category:Flora of South Asia]] | |||
[[Category:Flora of Southeast Asia]] | |||
[[Category:Ayurveda]] | |||
[[Category: Database of herbs and minerals | Herbs]] | [[Category: Database of herbs and minerals | Herbs]] | ||